Amprion Newsroom
Recent media coverage and announcements.
News Article
Drug Discovery News
Alpha synuclein reveals complexity behind Alzheimer’s and Parkinson’s diagnosis
April 21, 2026
Read MoreNews Article
Clinical Lab Products
Blood-Based Biomarkers Are Advancing Alzheimer’s Testing
Jul 16, 2025
Read MoreNews Article
Bio-IT World
uniQure’s Huntington’s Disease Trial Shows Promising Results
October 16, 2025
Read MoreNews Article
Clinical Leader
How Redefining The Diagnostic Odyssey Can Lead To Better Patient Outcomes
October 22, 2025
Read MorePodcast
Diagnosing Dx
The 20-Year Head Start: How Amprion Is Transforming Neurodiagnostics
Decemer 1, 025
Read MoreNews Article
The Pathologist
Inside the Race to Detect Neurodegenerative Disease Early
November 27, 2025
Read MoreNews Article
DiagnosticsWorld
Trendspotting: Precision Diagnostics, Artificial Intelligence, Data Management, Collection
January 6, 2026
Read MoreNews Article
PharmaVoice
New diagnostics define drug targets for Alzheimer’s, Parkinson’s and beyond
February 9, 2026
Read MorePress Release
Business Wire
Amprion Grows Global Footprint with Australian Partnership & Expanded Research Collaborations
April 1, 2026
Read MorePress Release
Business Wire
Amprion Announces Strategic Growth Initiatives, Expanding Access to Breakthrough SAAmplify Test
July 23, 2025
Read MoreNews Article
Technology Networks
Amprion Unveils Next-Generation SAAmplify™ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024
8/1/2024
Read MorePress Release
PR Newswire
Amprion's αSyn Seed Amplification Assay (αS-SAA) Highlighted in 10 Presentations at AD/PD™ 2024 International Conference
3/4/2024
Read More
Get in the Know
Bring biological certainty to your diagnosis with Amprion's SAAmplify-É‘SYN test. Order your shipping kits today and help move your patient beyond a probable diagnosis.
